Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.02 USD | +0.84% | +7.23% | -24.31% |
May. 15 | Earnings Flash (CDTX) CIDARA THERAPEUTICS Posts Q1 Revenue $8.5M | MT |
Apr. 25 | Top Premarket Gainers | MT |
Evolution of the average Target Price on Cidara Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Cidara Therapeutics, Inc.
HC Wainwright | |
Wedbush | |
Maxim | |
Aegis Capital |
EPS Revisions
- Stock Market
- Equities
- CDTX Stock
- Consensus Cidara Therapeutics, Inc.